Circulating adiponectin in patients with nonalcoholic fatty liver disease‐related liver fibrosis: A systematic review and a meta‐analysis-Reference-Cited by-同舟云学术

Circulating adiponectin in patients with nonalcoholic fatty liver disease‐related liver fibrosis: A systematic review and a meta‐analysis

Published:2022-07-15 Issue:10 Volume:37 Page:1853-1864
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:J of Gastro and Hepatol

Author:

Tontikidou Christina¹,Makri Evangelia S¹,Evripidou Kleo¹,Goulis Dimitrios G²,Goulas Antonis¹,Polyzos Stergios A¹^ORCID

Affiliation:

1. First Laboratory of Pharmacology, School of Medicine Aristotle University of Thessaloniki Thessaloniki Greece

2. Department of Endocrinology and Reproduction, First Department of Obstetrics and Gynecology, School of Medicine Aristotle University of Thessaloniki Thessaloniki Greece

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jgh.15926

Reference41 articles.

1. Nonalcoholic fatty future disease

2. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement

3. Commentary: Nonalcoholic or metabolic dysfunction-associated fatty liver disease? The epidemic of the 21st century in search of the most appropriate name

4. Nonalcoholic Fatty Liver Disease

5. Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Redox Homeostasis and Non-Invasive Assessment of Significant Liver Fibrosis by Shear Wave Elastography;Diagnostics;2024-09-03

2. Animal studies of sodium-glucose co-transporter 2 inhibitors in nonalcoholic fatty liver disease;Annals of Gastroenterology;2024

3. The role of glucagon-like peptide-1 receptor agonists in nonalcoholic fatty liver disease;Expert Review of Clinical Pharmacology;2023-10-27

4. A systematic review and meta-analysis of cohort studies on the potential association between NAFLD/MAFLD and risk of incident atrial fibrillation;Frontiers in Endocrinology;2023-07-05

5. The monocyte-to-high-density lipoprotein ratio is associated with the occurrence of atrial fibrillation among NAFLD patients: A propensity-matched analysis;Frontiers in Endocrinology;2023-03-28